Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
09/2009
09/16/2009EP2099792A1 Heterotricyclic metalloprotease inhibitors
09/16/2009EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents
09/16/2009EP2099751A1 Biphenyl-substituted spirocyclic ketoenols
09/16/2009EP2099747A1 Radiolabelling via fluorination of aziridines
09/16/2009EP2099303A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy
09/16/2009EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/16/2009CN101531664A Method for synthesizing a series of camptothecin substituted cinnamate
09/16/2009CN100540538C Large conductance calcium-activated k channel opener
09/15/2009US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor;
09/15/2009US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization
09/15/2009US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus
09/15/2009US7589068 Inhibitors of Akt activity
09/15/2009CA2230824C Process for the preparation of galanthamine and its derivatives
09/11/2009WO2009111337A1 Compounds and compositions as tlr activity modulators
09/11/2009WO2009110520A1 Heterocyclic compound
09/11/2009WO2009110007A1 Spiro derivatives of parthenin as novel anticancer agents
09/11/2009WO2009109608A1 Novel compounds
09/11/2009WO2009037570A3 Pyridine derivatives and methods of use thereof
09/11/2009CA2728855A1 Spiro derivatives of parthenin as novel anticancer agents
09/11/2009CA2717013A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
09/11/2009CA2716706A1 Compounds and compositions as tlr activity modulators
09/10/2009US20090227617 Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy
09/09/2009EP2098512A1 Compounds and methods for treating dyslipidemia
09/09/2009EP2097420A1 Spiroketone acetyl-coa carboxylase inhibitors
09/09/2009EP2097419A1 Benzofuropyrimidinones as protein kinase inhibitors
09/09/2009EP2097402A1 Macrocyclic inhibitors of hepatitis c virus
09/09/2009EP2097400A2 Fused substituted aminopyrrolidine derivative
09/09/2009EP2097376A2 Spiro-piperidine derivatives
09/09/2009EP2096917A2 Cyclopamine analogs
09/09/2009EP1670768B1 Compounds and methods for treating dyslipidemia
09/09/2009CN101528750A Benzimidazole derivatives as selective acid pump inhibitors
09/09/2009CN100537574C Preventive or therapeutic agent for diabetic maculopathy
09/09/2009CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
09/08/2009US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2287558C Heterocyclic derivatives and their use as antithrombotic agents
09/03/2009WO2009108838A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof
09/03/2009WO2009108827A1 Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
09/03/2009WO2009087379A3 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases
09/03/2009US20090221826 Process for making topotecan
09/03/2009US20090221699 Fab I Inhibitors
09/03/2009US20090221597 Heteroaryl derivatives as cftr modulators
09/03/2009CA2716798A1 Tetrahydrofuropyridones
09/03/2009CA2716499A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof
09/02/2009EP2096490A1 Display element and method of driving the same
09/02/2009EP2096113A1 9-substituted camptothecin derivatives as antitumor compounds
09/02/2009EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
09/02/2009EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/02/2009EP1458392B1 Acridones as inhibitors of impdh enzyme
09/02/2009CN101522686A Methods of making esters of camptothecins
09/02/2009CN101522685A Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
09/02/2009CN101522684A 6-carboxy-normorphinan derivatives, synthesis and uses thereof
09/02/2009CN101519407A Synthesis method of cyclic acid anhydride capable of having substituent group
09/02/2009CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof
09/02/2009CN101519386A Large conductance calcium-activated K channel opener
09/02/2009CN100534993C Spiropyran compound with isocyanate trimer and its preparation method and application
09/01/2009US7582752 Process for the resolution of nefopam
09/01/2009US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
09/01/2009US7582658 Bicyclic compound
09/01/2009US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
09/01/2009US7582641 Gyrase inhibitors and uses thereof
09/01/2009US7582632 Tri(cyclo) substituted amide compounds
09/01/2009CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence
08/2009
08/27/2009WO2009105507A2 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2009086028A3 Carbazole-containing materials in phosphorescent light emitting diodes
08/27/2009US20090216028 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
08/27/2009US20090216012 Use of centrifugal partition chromatography for purifying galanthamine
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009CA2716349A1 Methods for inhibiting drug degradation
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2715192A1 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
08/26/2009EP2091935A2 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
08/26/2009EP1861105B1 Process for the preparation of galanthamine hydrobromide
08/26/2009EP1791539B1 Process to prepare camptothecin derivatives
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009CN101516890A Diaryl ketimine derivative
08/26/2009CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
08/26/2009CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
08/25/2009US7579419 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices
08/25/2009US7579411 Process for the controlled increase in the molecular weight of polyethylenes
08/25/2009US7579359 imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines; immunomodulators for inducing cytokine biosynthesis; for treatment of viral and neoplastic diseases
08/25/2009US7579356 Thia-tetraazaacenaphthylene kinase inhibitors
08/25/2009US7579022 Photochromic compounds
08/25/2009CA2366932C Cyclic protein tyrosine kinase inhibitors
08/20/2009WO2009103032A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
08/20/2009WO2009102633A1 Hepatitis c virus inhibitors
08/20/2009US20090209608 Deuterium-enriched asenapine
08/20/2009US20090209572 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders
08/20/2009US20090209566 Spirocyclic Compounds
08/20/2009CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
08/20/2009CA2715559A1 Hepatitis c virus inhibitors
08/20/2009CA2714087A1 Inhibitors of checkpoint kinases
08/20/2009CA2707442A1 Antibiotic tetrahydro-beta-carboline derivatives
08/19/2009EP2089395A2 New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities
08/19/2009EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists
08/19/2009EP2089381A1 Indoles which act as via receptor antagonists
08/19/2009CN101511841A Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors
08/19/2009CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
08/19/2009CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 298